Original language | English |
---|---|
Pages (from-to) | 226-228 |
Number of pages | 3 |
Journal | Hong Kong Medical Journal |
Volume | 27 |
Issue number | 3 |
DOIs |
|
Publication status | Published - Jun 2021 |
ASJC Scopus subject areas
- Medicine(all)
More information
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Lessons learnt from a genetic disease registry in hong kong. / Lam, Stephen T.S.; To, C. H.; Leung, K. W. et al.
In: Hong Kong Medical Journal, Vol. 27, No. 3, 06.2021, p. 226-228.Research output: Journal article publication › Comment/debate/erratum
TY - JOUR
T1 - Lessons learnt from a genetic disease registry in hong kong
AU - Lam, Stephen T.S.
AU - To, C. H.
AU - Leung, K. W.
AU - Yip, S. P.
AU - Lo, Ivan F.M.
AU - Tsang, K. P.
N1 - Funding Information: A rare genetic eye disorder, RP causes progressive visual loss due to degeneration of cells in the retina, estimated to affect 1 in 4000 people in the United States and worldwide.1 There are, however, no reported prevalence data in Hong Kong. The diagnosis of RP is based on the clinical features which include symptoms of night vision impairment and tunnel vision, and the findings of typical retinal appearance of attenuated blood vessels, so-called bone spicule pigmentation or its variant appearance and an atrophic optic disc. These are supported by an abnormal constricted visual field and a non-recordable or abnormal electroretinography with diminished a and b waves with increased implicit time. The RP is also highly genetically heterogeneous, with more than 80 genes implicated and their mode of inheritance varies. This means one patient’s RP may be a different genetic disorder from that of another RP patient, with different inheritance, natural course, and prognosis. The rarity of the disease and the associated genetic heterogeneity are major obstacles to facilitating research and enhancing medical care to these patients and their families. The Hong Kong Retinitis Pigmentosa Society was started in 1995 as a patient group, and subsequently renamed as Retina Hong Kong. Under the auspices of Retina Hong Kong, a Scientific and Medical Advisory Committee (SMAC) was established. In 1997, the SMAC secured a grant from the Healthcare and Promotion Fund of the Hong Kong Government to start organising the Hong Kong Patients Registry of Retinal Degenerations. It was the original intention for this registry to cover most retinal degenerative conditions. However, because of resource constraints, it was decided that the scope should be limited to RP as the first group of members to be covered. Hence, the registry was also abbreviated as the Hong Kong Retinitis Pigmentosa Registry. It turned out to be the first registry of its kind among Chinese populations in the whole world, and to the best of our knowledge, there is no other Chinese Registry presently.
PY - 2021/6
Y1 - 2021/6
UR - http://www.scopus.com/inward/record.url?scp=85109382524&partnerID=8YFLogxK
U2 - 10.12809/hkmj208659
DO - 10.12809/hkmj208659
M3 - Comment/debate/erratum
C2 - 34168092
AN - SCOPUS:85109382524
SN - 1024-2708
VL - 27
SP - 226
EP - 228
JO - Journal of the Hong Kong Medical Association
JF - Journal of the Hong Kong Medical Association
IS - 3
ER -